Biosimilars Asia:Collaborative Development and Successful Commercialisation

Biosimilars Asia
20-23 May 2014
Grand Hyatt Shanghai, China
www.biosimilarsasia.com

Collaborative Development and Successful Commercialisation

China remains an attractive destination for MNCs and regionals pharma players for biosimilars development. Risks are reduced through strategic alliances and partnerships with local Chinese manufacturers.

IBC’s 5th Annual Biosimilars Asia will bring together senior level biosimilars development, manufacturing and commercialization decision makers from Asia and globally. It provides an unrivalled platform to find solutions to the most pressing strategic challenges as well as innovations in development of biosimilars.

5th Annual Biosimilars Asia is co-located with Cell Line Development and Engineering Asia and Biomanufacturing 2014 as part of the Biopharma Development & Production (BDP) Week.

About Biopharma Development & Production Week The Biopharma Development & Production Week is the leading industry platform for pharma, biotech, CMOs, CROs, research institutes, investors and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia.  For more information visitwww.biopharmaproduction.com

Contact Details:
Email: register@ibcasia.com.sg
Telephone: +65 6508 2401 / China: +86 21 23 3680
Fax: +65 6508 2407
Mail: IBC Asia (S) PTE LTD, 111 Somerset Road, TripleOne Somerset #10-06 Singapore 238164